Literature DB >> 11380309

Subject and observer-rated quality of life in schizophrenia.

P B Fitzgerald1, C L Williams, N Corteling, S L Filia, K Brewer, A Adams, A R de Castella, T Rolfe, P Davey, J Kulkarni.   

Abstract

OBJECTIVE: We aimed to explore the relationship between objectively rated quality of life and subjective measures of social functioning and life satisfaction.
METHOD: Participants of the Schizophrenia Care and Assessment Program (SCAP) study at Dandenong in Australia were included in this analysis. Subjective ratings of several domains of social functioning and life satisfaction were taken from the SCAP instrument and comparisons made with data from the Quality of Life scale rated by research staff as well as several psychopathology measures.
RESULTS: Subjectively reported life satisfaction was not related to positive or negative symptoms of schizophrenia but did correlate with depressive symptoms. Quality of Life scale measures correlated with negative symptoms on most domains. There was very limited overlap in domain items between the life satisfaction and quality of life measures.
CONCLUSION: Life satisfaction and objectively rated quality of life are not closely related and appear to have different determinants in patients with schizophrenia.

Entities:  

Mesh:

Year:  2001        PMID: 11380309     DOI: 10.1034/j.1600-0447.2001.00254.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  34 in total

1.  Ten-year quality of life outcomes among patients with schizophrenia and schizoaffective disorder II. Predictive value of psychosocial factors.

Authors:  Michael S Ritsner; Marina Arbitman; Alexander Lisker; Alexander M Ponizovsky
Journal:  Qual Life Res       Date:  2011-10-02       Impact factor: 4.147

2.  Validity of an abbreviated quality of life enjoyment and satisfaction questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients.

Authors:  Michael Ritsner; Rena Kurs; Anatoly Gibel; Yael Ratner; Jean Endicott
Journal:  Qual Life Res       Date:  2005-09       Impact factor: 4.147

3.  Subjective quality of life of community living Sudanese psychiatric patients: comparison with family caregivers' impressions and control group.

Authors:  A W Awadalla; J U Ohaeri; A A Salih; A M Tawfiq
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

4.  Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis.

Authors:  Shaun M Eack; Christina E Newhill
Journal:  Schizophr Bull       Date:  2007-01-04       Impact factor: 9.306

5.  Determinants of changes in perceived quality of life in the course of schizophrenia.

Authors:  Michael Ritsner; Anatoly Gibel; Yael Ratner
Journal:  Qual Life Res       Date:  2006-04       Impact factor: 4.147

6.  Ten-year quality of life outcomes among patients with schizophrenia and schizoaffective disorders: I. Predictive value of disorder-related factors.

Authors:  Michael S Ritsner; Alexander Lisker; Marina Arbitman
Journal:  Qual Life Res       Date:  2011-09-13       Impact factor: 4.147

7.  Enzyme replacement therapy and extended newborn screening for mucopolysaccharidoses: opinions of treating physicians.

Authors:  David J Coman; Ian M Hayes; Veronica Collins; Margaret Sahhar; J Ed Wraith; Martin B Delatycki
Journal:  JIMD Rep       Date:  2011-06-22

8.  Quality of Life in Schizophrenia: A Meta-Analysis of Comparative Studies.

Authors:  Min Dong; Li Lu; Ling Zhang; Yun-Shu Zhang; Chee H Ng; Gabor S Ungvari; Gang Li; Xiangfei Meng; Gang Wang; Yu-Tao Xiang
Journal:  Psychiatr Q       Date:  2019-09

9.  Symptomatic Remission Determines Functional Improvement and Quality of Life in Schizophrenia.

Authors:  Mehmet Hanifi Kokaçya; Osman Virit; Ümit Sertan Çöpoğlu; Haluk Savaş; Mustafa Ari; Bülent Bahçeci
Journal:  Noro Psikiyatr Ars       Date:  2016-12-01       Impact factor: 1.339

10.  Measurement of quality of life in schizophrenia: a comparison of two scales.

Authors:  Yvette Kusel; Richard Laugharne; Sian Perrington; Jan McKendrick; Deborah Stephenson; J Stockton-Henderson; Madeline Barley; R McCaul; Tom Burns
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-08-29       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.